Spinogenix, Inc.
Los Angeles, CA, US· latest recorded location
Spinogenix, Inc. is named on 4 US grants and 7 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 4
- Published applications
- 7
- Inventors
- 5
- Granted in 2026 so far
- 1
- Most recent grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2020 | 0 | 1 |
| 2021 | 1 | 1 |
| 2022 | 0 | 2 |
| 2023 | 0 | 0 |
| 2024 | 0 | 3 |
| 2025 | 2 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 11 documents
Recent patents
- Methods of treating spinal cord injury or damage15 Sep 2026US 12,734,159 B2
- Solid forms of a promoter of spinogenesis2 Dec 2025US 12,486,287 B2
- Benzothiazole and related compounds19 Aug 2025US 12,391,659 B2
- Benzothiazole and related compounds14 Sep 2021US 11,117,878 B2
- Fascin binding compounds for spinogenesis26 Dec 2024US 2024/0423962 A1
- Certain fascin binding compounds for spinogenesis6 Jun 2024US 2024/0180920 A1
- Methods of treating spinal cord injury or damage16 May 2024US 2024/0156791 A1
- Solid forms of a promoter of spinogenesis7 Apr 2022US 2022/0106330 A1
- Benzothiazole and related compounds20 Jan 2022US 2022/0017477 A1
Most cited
By later US patents